< Back to companies

Ascento-CDA is developing a First in The Industry Clinical Decision Support Solution (CDSS) for Cognitive Decline. The solution provides personalized, actionable data, enabling clinicians to implement remediation strategies, to slow, stop or in some cases – reverse the conditions of cognitive decline, dementia and Alzheimer’s disease (CDA). The technology is based on Multi-Factorial Machine Learning of extensive medical data, some of which is being pioneered by the company.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2023
Website
ascento-cda.com/

Categories

Clinical Decision SupportAI / MLDiagnosticsNeurology

Disease Areas

Technologies

Clinical Decision SupportMachine LearningAI/Machine LearningPredictive Analytics
Only accessible to MedStartr community members. Join now

What do you think of Ascento-CDA?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now